Matt WillemsenAug 24, 2024
A newly approved ‘living drug’ could save more cancer patients’ lives
https://www.sciencenews.org/article/newly-approved-drug-save-cancer-patient #medicine #treatment #cancer #TCellTherapy #SolidTumors #TILs #Amtagvi #lifileucel
A newly approved ‘living drug' could save more cancer patients' lives

Tumor-infiltrating lymphocyte, or TIL, therapy is the first T cell treatment for solid tumors. It fights melanoma and maybe other cancers too.

Science News
Howard Smith MD, AMMar 6, 2024
Last Resort Therapy For Advanced Melanoma: Loads of Tumor Infiltrating Lymphocytes (TILs) help control tumor. #melanoma #til #tumorinfiltratinglymphocyctes #Amtagvi #lifileucel #rosenberg #nci #fda
https://www.instagram.com/p/C4L-mmcrixL/